Table 3.
SFSR of combination compounds.a
| Cmpd | Structure | β-arrestin | cAMP | ||
|---|---|---|---|---|---|
| Emax (%) | EC50 (nM) | Emax (%) | EC50 (nM) | ||
| 46 | ![]() |
<20 | N/C | 43 | 98 |
| 47 | ![]() |
<20 | N/C | 33 | 72 |
| 48 | ![]() |
<20 | N/C | 33 | 62 |
| 49 | ![]() |
<20 | N/C | 32 | 8.3 |
| 50 | ![]() |
33 | 6.4 | 41 | 1.0 |
| 51 | ![]() |
36 | 16 | 48 | 2.8 |
| 52 | ![]() |
N/A | N/A | N/A | N/A |
| 53 | ![]() |
<20 | N/C | 37 | 5.5 |
| 54 | ![]() |
<20 | N/C | 47 | 50 |
| 55 | ![]() |
<20 | N/C | 31 | 28 |
| 56 | ![]() |
29 | 6.5 | 49 | 1.1 |
| 57 | ![]() |
N/A | N/A | N/A | N/A |
| 58 | ![]() |
24 | 460 | 56 | 88 |
EC50 and Emax values are the average of at least three independent experiments performed in triplicate. SEM: < ± 20%.
N/C. not calculated. N/A. no activity.












